Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Peripartum Cardiomyopathy, Postpartum: later-stage trial registry

1 of 1 indexed Peripartum Cardiomyopathy, Postpartum trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Peripartum Cardiomyopathy, Postpartum: 1 US clinical trial tracked, 1 recruiting.

Peripartum Cardiomyopathy, Postpartum is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Dennis M. McNamara, MD, MS, running 1 of these trials.

Enrollment posture brief

Registry condition peripartum-cardiomyopathy-postpartum

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Peripartum Cardiomyopath (this)Peripartum Cardiomyopath (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Peripartum Cardiomyopathy, Postpartum

Peripartum Cardiomyopathy, Postpartum lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peripartum Cardiomyopathy, Postpartum on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peripartum Cardiomyopathy, Postpartum is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Peripartum Cardiomyopathy, Postpartum records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Second Placebo Drug
1 trials
Rivaroxaban Drug
1 trials
Guideline Directed Medical Therapy for Heart Failure (GDMT) Drug
1 trials
Bromocriptine Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Peripartum Cardiomyopathy, Postpartum trials. A trial with sites in several states counts in each.

Kentucky 1 trials
Indiana 1 trials
Illinois 1 trials
Iowa 1 trials
Georgia 1 trials
Florida 1 trials
Connecticut 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peripartum Cardiomyopathy, Postpartum page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Peripartum Cardiomyopathy, Postpartum trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Dennis M. McNamara, MD, MS sponsors the most Peripartum Cardiomyopathy, Postpartum trials on record, review their full trial history before evaluating a specific study. See Dennis M. McNamara, MD, MS's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripartum Cardiomyopathy, Postpartum condition card totals 1 registered trials; most-linked intervention Second Placebo; top US site state Kentucky. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.